Alimera Sciences Inc reports results for the quarter ended in December - Earnings Summary

Alimera Sciences

31/03/2023 14:31

* Alimera Sciences Inc  ALIM.OQ  reported a quarterly
adjusted
loss of 54 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 33 cents per share.
    * Revenue rose 0.5% to $14.03 million from a year ago;
analysts
expected $14.62 million. 
    * Alimera Sciences Inc's reported EPS for the quarter was a
loss
of 54 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Alimera Sciences Inc shares had fallen by 34.3% this
quarter.
    * The company reported a quarterly loss of $3.78 million.
    * Wall Street's median 12-month price target for Alimera
Sciences
Inc is $6.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 31 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.33          -0.54          Missed
 Sep. 30 2022      -0.40          -0.75          Missed
 Jun. 30 2022      -0.55          -0.45          Beat
 Mar. 31 2022      -0.69          -0.85          Missed